Selected Quarterly Financial Data (Details) - USD ($) |
3 Months Ended | 12 Months Ended | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|||||||||||
| Quarterly Financial Information Disclosure [Abstract] | |||||||||||||||||||||
| Lymphoseek sales revenue | $ 2,332,000 | $ 6,690,000 | $ 4,232,000 | $ 3,783,000 | $ 2,953,000 | $ 3,503,000 | $ 1,964,000 | $ 1,835,000 | $ 17,037,098 | $ 10,254,352 | $ 4,233,953 | ||||||||||
| Lymphoseek license revenue | 0 | 1,296,000 | 246,000 | 254,000 | 550,000 | 250,000 | 250,000 | 83,000 | 1,795,625 | 1,133,333 | 300,000 | ||||||||||
| Grant and other revenue | 1,023,000 | 511,000 | 917,000 | 686,000 | 477,000 | 541,000 | 654,000 | 190,000 | 3,136,983 | 1,861,622 | 1,740,896 | ||||||||||
| Gross profit | 3,076,000 | 7,575,000 | 4,834,000 | 4,188,000 | 3,522,000 | 3,778,000 | 2,535,000 | 1,659,000 | 19,672,666 | 11,494,544 | 4,688,704 | ||||||||||
| Operating expenses | 5,509,000 | 4,217,000 | 5,414,000 | 6,756,000 | 7,845,000 | 6,379,000 | 6,346,000 | 9,475,000 | 21,896,141 | 30,045,062 | 32,321,660 | ||||||||||
| Operating income (loss) | (2,433,000) | 3,358,000 | (580,000) | (2,568,000) | (4,323,000) | (2,601,000) | (3,811,000) | (7,816,000) | (2,223,475) | (18,550,518) | (27,632,956) | ||||||||||
| Net loss attributable to common stockholders | $ (3,883,000) | $ (59,000) | $ (6,681,000) | $ (3,686,000) | $ (8,071,000) | $ (2,510,000) | $ (9,691,000) | $ (7,337,000) | $ (14,308,383) | $ (27,608,680) | $ (35,726,669) | ||||||||||
| Basic and diluted net loss per share | $ (0.03) | [1] | $ (0.00) | [1] | $ (0.04) | [1] | $ (0.02) | [1] | $ (0.05) | [1] | $ (0.02) | [1] | $ (0.06) | [1] | $ (0.05) | [1] | $ (0.09) | $ (0.18) | $ (0.24) | ||
| |||||||||||||||||||||
| X | ||||||||||
- Definition Grant and other revenue. No definition available.
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|